Results 221 to 230 of about 204,272 (330)

The pulmonary artery pulsatility index in patients with severe aortic stenosis undergoing valve replacement

ESC Heart Failure, EarlyView.
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner, Lukas Weber, Philipp K. Haager, Johannes Rigger, Joannis Chronis, Peter Ammann, Roman Brenner, Martin O. Schmiady, Hans Rickli, Micha T. Maeder   +9 more
wiley   +1 more source

A network meta-analysis comparative the efficacy of angiotensin-converting enzyme inhibitors and calcium channel blockers in hypertension. [PDF]

Medicine (Baltimore)
Yao YJ, Gui M, Cai SK.
europepmc   +1 more source

The Effects of Nephrectomy and Angiotensin Converting Enzyme Inhibitor on Production and Clearance rates of Antiotensinogen in Dogs

, 1989
N Toyozaki, Teizo Ito
openalex   +2 more sources

Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis

Circulation, 2004
R. Rosenhek, F. Rader, N. Loho, H. Gabriel, M. Heger, U. Klaar, M. Schemper, T. Binder, G. Maurer, H. Baumgartner   +9 more
semanticscholar   +1 more source

Circulating CD19 B cell count, myocardial injury and clinical outcomes in patients with heart failure

ESC Heart Failure, EarlyView.
Circulating CD19 B cell counts negatively correlated with myocardial injury. CD19 B cell count was an independent predictor for all‐cause mortality and HF‐related events, but not other lymphocyte subsets. Circulating CD19 B cell counts correlated to myocardial injury and could be a feasible marker for clinical outcomes in patients with HF.
Yuta Kobayashi, Yoichiro Otaki, Tetsu Watanabe, Ryuhei Yamaguchi, Hiroe Ono, Shingo Tachibana, Junya Sato, Naoaki Hashimoto, Masahiro Wanezaki, Daisuke Kutsuzawa, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Efficacy of Beta-Blockers and Angiotensin-Converting Enzyme Inhibitors in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

Cardiol Res
Llerena-Velastegui J, Santamaria-Lasso M, Mejia-Mora M, Santander-Aldean M, Granda-Munoz A, Hurtado-Alzate C, de Jesus ACFS, Baldelomar-Ortiz J.   +7 more
europepmc   +1 more source

Effects of angiotensin II converting enzyme inhibitor enarapril on autonomic nervous system.

, 1988
Yuji Kumagai
openalex   +2 more sources

Initial clinical experience with dapagliflozin in addition to optimized medical therapy in paediatric heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal, Oliver Miera, Annemarie Krauss, Friederike Danne, Felix Berger, Peter Kramer   +5 more
wiley   +1 more source

The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors. [PDF]

Iran J Med Sci
Abd-El-Fatah SS, Fathy MA, Alabiad MA, Aljafil R, Gobran MA, Ahmad EA, Alsharidah AS, Alorini M, Alnasser SM, Awadh SA, Morgan EN.   +10 more
europepmc   +1 more source

Pharmacodynamics and pharmacokinetics of ramipril (Hoe 498), an angiotensin converting enzyme (ACE) inhibitor, in dogs

, 1986
Mikio Omosu, Hiroko Yamazaki, Shoryo Hayashi, Takashi Sakaguchi   +3 more
openalex   +1 more source